title: [CD30 (Ki-1+) anaplastic large cell lymphomas].
authors: Service de Dermatologie, Hôpital Henri-Mondor, Créteil.
authors: M
authors: M
authors: Bagot
authors: J
authors: J
authors: Wechsler
authors: A
authors: A
authors: Cosnes
authors: C
authors: C
authors: Haioun
authors: M
authors: M
authors: Divine
authors: P
authors: P
authors: Gaulard
authors: T
authors: T
authors: Henni
authors: J
authors: J
authors: Revuz
mesh_terms: D000328:Adult; D000943:Antigens, Differentiation / Q000276:immunology; D000951:Antigens, Neoplasm / Q000276:immunology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor; D001761:Bleomycin / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D017730:Ki-1 Antigen; D008223:Lymphoma / Q000188:drug therapy / Q000276:immunology / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D010641:Phenotype; D011379:Prognosis; D012878:Skin Neoplasms / Q000188:drug therapy / Q000276:immunology / Q000473:pathology*; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D000943:Antigens, Differentiation; D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D017730:Ki-1 Antigen; D001761:Bleomycin; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide
vernacular_title: Lymphomes à grandes cellules anaplasiques CD30 (Ki-1)+.